Akoya Biosciences, Inc.
NASDAQ:AKYA
2.49 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 83.125 | 74.229 | 113.079 | 17.006 | 11.636 |
| Short Term Investments
| 0 | 6.989 | 0 | 0 | 10.023 |
| Cash and Short Term Investments
| 83.125 | 81.218 | 113.079 | 17.006 | 21.659 |
| Net Receivables
| 16.994 | 9.729 | 9.444 | 6.47 | 13.167 |
| Inventory
| 17.877 | 14.486 | 9.014 | 4.263 | 4.093 |
| Other Current Assets
| 3.794 | 6.764 | 13.461 | 0.957 | 1.955 |
| Total Current Assets
| 121.79 | 112.197 | 140.814 | 28.696 | 40.874 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 20.656 | 22.449 | 7.487 | 5.528 | 4.983 |
| Goodwill
| 18.262 | 18.262 | 18.262 | 18.262 | 18.262 |
| Intangible Assets
| 17.412 | 20.048 | 21.15 | 22.714 | 24.137 |
| Goodwill and Intangible Assets
| 35.674 | 38.31 | 39.412 | 40.976 | 42.399 |
| Long Term Investments
| 0 | 0.303 | 0.302 | 0.502 | 0.501 |
| Tax Assets
| 0 | -0.303 | -0.302 | -0.502 | -0.501 |
| Other Non-Current Assets
| 2.249 | 3.075 | 3.194 | 2.46 | 1.157 |
| Total Non-Current Assets
| 58.579 | 63.834 | 50.093 | 48.964 | 48.539 |
| Total Assets
| 180.369 | 176.031 | 190.907 | 77.66 | 89.413 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 11.776 | 10.628 | 9.435 | 5.074 | 8.119 |
| Short Term Debt
| 6.896 | 7.258 | 0.544 | 1.229 | 0.08 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 6.688 | 6.279 | 4.484 | 3.844 | 4.375 |
| Other Current Liabilities
| 9.985 | 12.89 | 13.219 | 7.015 | 8.581 |
| Total Current Liabilities
| 35.345 | 37.055 | 27.682 | 17.162 | 21.155 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 82.258 | 72.155 | 32.668 | 33.765 | 24.671 |
| Deferred Revenue Non-Current
| 3.193 | 2.114 | 1.33 | 1.008 | 0.905 |
| Deferred Tax Liabilities Non-Current
| 0.038 | 0.087 | 0.026 | 0.17 | 0.163 |
| Other Non-Current Liabilities
| 5.765 | 6.039 | 7.85 | 6.984 | 72.678 |
| Total Non-Current Liabilities
| 91.254 | 80.395 | 41.874 | 41.927 | 98.417 |
| Total Liabilities
| 126.599 | 117.45 | 69.556 | 59.089 | 119.572 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 190.907 | 70.36 | 1.253 |
| Common Stock
| 0.002 | 0.002 | 0.002 | 0.002 | 0.001 |
| Retained Earnings
| -230.071 | -166.748 | -96.107 | -52.28 | -31.413 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.006 | -190.907 | -70.36 | -0.001 |
| Other Total Stockholders Equity
| 283.839 | 225.333 | 26.549 | 0.49 | 0.001 |
| Total Shareholders Equity
| 53.77 | 58.581 | 121.351 | 18.571 | -30.159 |
| Total Equity
| 53.77 | 58.581 | 121.351 | 18.571 | -30.159 |
| Total Liabilities & Shareholders Equity
| 180.369 | 176.031 | 190.907 | 77.66 | 89.413 |